Rho

This is what 40 years of a strong culture and company mission looks like! It was a vibrant, active week at Rho's Durham office this week. From our "Techapalooza" where members of our IT team hosted sessions on our tech stack to our big, international 40-year anniversary celebration, our office was buzzing with activity and colleagues (and their families)! Our global colleagues in the Ukraine, Latvia, and Poland joined in from their locations, as well, many bringing their families along for the celebration, too. The entire Rho team is ready to dive into our next decade! Want to join us? Check out job openings: https://lnkd.in/eWtAm8vc

Navigating the complexities of rare disease drug development requires a strategic approach, especially when it comes to statistical challenges. Early and frequent communication with regulatory authorities can pave the way for novel statistical methods. Learn more about how to effectively engage with the FDA and other agencies to overcome these hurdles. Dive into our latest blog post for detailed insights from our Associate Director, Biostatistics, Patricia Stephenson: https://bit.ly/3xOdBVd

Big congratulations to Swing Therapeutics, Inc. on the outstanding results published today! This is a gamechanger for the fibromyalgia community, offering new hope and relief. We are excited to see the continued positive impacts from this work!

🚨 Breaking News: President Biden has signed the National Plan to End Parkinson’s Act into law! This is the first-ever federal legislation dedicated to ending Parkinson’s disease. This monumental bill can make an impact by: 💵 Dramatically increasing federal research funding 🔬 Developing more effective pathways for treatments and cures 🩺 Improving early diagnosis 🥼 Sparking new and improved models for patient care ⚖️ Addressing health disparities in diagnosis, treatment, and clinical trial participation We would like to thank all the Parkinson’s advocates, volunteers and people who wrote to their senators and representatives to make this bill become law. “The Parkinson’s Foundation is excited for what comes next,” said John Lehr, Parkinson’s Foundation President and CEO. “We look forward to having input in designing exactly how this bill will mobilize meaningful change for the one million Americans living with this disease.” Learn more: https://lnkd.in/gNU9tYc8

We are excited that, earlier this year, FDA has approved Xolair as the first medicine for reducing allergic reactions to multiple food allergens in patients aged one year and older as a result of the NIH-sponsored Phase III OUtMATCH study. Rho is proud to have been a part of this achievement in food allergy research. For more information about the study, visit bit.ly/NewsFoodAllergies Here’s why this is so important to so many people: Food allergies have increased significantly over the last two decades, putting more people at risk for severe reactions. With food allergies being the most common cause of anaphylaxis, it's encouraging to see groundbreaking advancements in allergy treatment. 

We are firm believers that an active lifestyle and time spent outdoors can have a huge impact on an individual's overall well-being. As we spend more time outside, it is important to recognize the negative effects of prolonged sun exposure. Harmful UV radiation can lead to sunburn, premature aging, and even skin cancer. Sun exposure can also worsen existing skin conditions due to increased inflammation, sensitivity, and hyperpigmentation. Everyone should protect themselves against the sun, but those with pre-existing skin concerns should be extra cautious to prevent exacerbating their condition. #SunSafety #DermatologyCRO #SkinProtection

We are humbled to announce that we have been recognized by Triangle Business Journal as one of the 2024 Best Places to Work! This honor reflects the culture our team has fostered over the last 40 years. We applaud our employees for their collaborative spirit, trust and support of one another, openness to adaptability and innovation, and dedication to our purpose to improve health. Our team’s commitment to live out our values every day is what makes Rho a great place to work. That’s what it means to #ExperienceRho

Great meeting with Veerle and Anne from the ECFS-CTN at the ECFS conference in Glasgow! Thankful to be representing Rho and the important collaborations and research we do everyday to search for a cure cystic fibrosis! Caitlin Hirschman Egle Garbuziene Crystal Azoca

Congratulations Peter Schmidt, on your groundbreaking paper! We look forward to seeing how this work influences future studies and clinical practices. Well done!

Our SLEEP dream team is in Houston. Be sure to meet up with them and join in the effort to advance sleep research.